Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JMJD6 | Q6NYC1 | 6/20 | 0.57 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | NPC1 | O15118 | 3/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | KDM1A | O60341 | 2/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | KDM5A | P29375 | 1/20 | 0.48 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28334801 | 0.89 | JMJD6 (0.57) | JMJD6MAPTNPC1RAB9AL3MBTL1 | |
| SCHEMBL4763737 | 0.87 | JMJD6 (0.61) | JMJD6MAPTNPC1RAB9AKDM1A | |
| SCHEMBL31211636 | 0.86 | JMJD6 (0.57) | JMJD6MAPTNPC1RAB9AL3MBTL1 | |
| SCHEMBL25003822 | 0.86 | KDM4E (0.63) | JMJD6MAPTNPC1RAB9AL3MBTL1 | |
| SCHEMBL4768424 | 0.86 | JMJD6 (0.54) | JMJD6MAPTALDH1A1HPGDKDM4E | |
| SCHEMBL4763698 | 0.85 | JMJD6 (0.64) | JMJD6MAPTNPC1RAB9AALDH1A1 | |
| SCHEMBL4770697 | 0.85 | JMJD6 (0.59) | JMJD6MAPTNPC1RAB9AL3MBTL1 | |
| SCHEMBL4768876 | 0.85 | JMJD6 (0.59) | JMJD6MAPTNPC1RAB9AALDH1A1 | |
| SCHEMBL4763680 | 0.85 | JMJD6 (0.67) | JMJD6MAPTNPC1RAB9AALDH1A1 | |
| SCHEMBL4774129 | 0.84 | HTT (0.57) | JMJD6MAPTNPC1HDAC1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105685064-A | HERBICIDAL ISOXAZOLO[5,4-b]PYRIDINES | 巴斯夫欧洲公司 | 2016-06-22 | — | — | CN | claimed |
| CN-105685064-B | Weeding isoxazoles simultaneously [5,4-b] pyridine | 巴斯夫欧洲公司 | 2018-06-22 | — | — | CN | disclosed |
| CN-105685064-A | HERBICIDAL ISOXAZOLO[5,4-b]PYRIDINES | 巴斯夫欧洲公司 | 2016-06-22 | — | — | CN | disclosed |
| EP-1400513-B1 | UNSYMMETRICAL CYCLIC DIAMINE COMPOUND | KOWA CO (JP) | 2008-01-09 | — | — | EP | disclosed |
| EP-1400513-A1 | UNSYMMETRICAL CYCLIC DIAMINE COMPOUND | Kowa Co., Ltd. (JP) | 2004-03-24 | — | — | EP | disclosed |
| US-6552188-B2 | Inhibit cell adhesion and cell infiltration; useful treating asthma, allergies, rheumatic diseases, arteriosclerosis, and inflammation; 2-(3,4,5-trimethoxyphenyl),4-((4-substituted piperazin-1-yl)methyl)pyridine compounds | KOWA CO., LTD. (JP) | 2003-04-22 | — | — | US | disclosed |
| US-20030022887-A1 | Unsymmetrical cyclic diamine compound | KOWA CO., LTD. (JP) | 2003-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030022887-A1 | Unsymmetrical cyclic diamine compound | H1-0, DDAH1, AOC1 | JMJD6 1967/4885MAPT 4305/4885NPC1 84/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.